| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 86 |
| 1 | CICLESONIDE | 55 |
| 2 | ERGOCALCIFEROL | 45 |
| 3 | MONTELUKAST SODIUM | 45 |
| 4 | ALBUTEROL SULFATE | 38 |
| 5 | TIOTROPIUM BROMIDE | 38 |
| 6 | ASPIRIN | 35 |
| 7 | ASPIRIN 325 MG | 35 |
| 8 | ASPIRIN 81 MG | 35 |
| 9 | MEPOLIZUMAB | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLUTATHIONE | 15 | 0.0087 |
| 1 | THIOGUANINE | 17 | 0.0080 |
| 2 | OMEGA-3-ACID ETHYL ESTERS | 12 | 0.0062 |
| 3 | CICLESONIDE | 55 | 0.0040 |
| 4 | ILOPROST | 3 | 0.0032 |
| 5 | MERCAPTOPURINE | 27 | 0.0015 |
| 6 | ERGOCALCIFEROL | 45 | 0.0015 |
| 7 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 32 | 0.0009 |
| 8 | MEPOLIZUMAB | 35 | 0.0007 |
| 9 | ALBENDAZOLE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 116 |
| 1 | Provitamin D2 Compound [EPC] | 45 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 37 |
| 3 | Interleukin-5 Antagonist [EPC] | 35 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 35 |
| 5 | Purine Antimetabolite [EPC] | 30 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 29 |
| 7 | Interleukin-4 Receptor alpha Antagonist [EPC] | 26 |
| 8 | Proton Pump Inhibitor [EPC] | 24 |
| 9 | Alkylating Drug [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 35 | 0.0509 |
| 1 | Prostacycline [EPC] | 3 | 0.0032 |
| 2 | Provitamin D2 Compound [EPC] | 45 | 0.0015 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | Antiparasitic [EPC] | 2 | 0.0004 |
| 5 | Pediculicide [EPC] | 2 | 0.0004 |
| 6 | Anthelmintic [EPC] | 1 | 0.0003 |
| 7 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 7 | 0.0003 |
| 8 | Leukotriene Receptor Antagonist [EPC] | 9 | 0.0003 |
| 9 | Purine Antimetabolite [EPC] | 30 | 0.0003 |